tirzepatide thyroid Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Dysfunction Following Use Tirzepatide for Hypothyroidism Weight Loss

The best way to really determine whether one of these treatments may be right for you is to work with a qualified and knowledgeable medical provider

Methylcobalamin is the bioactive form preferred by some researchers over cyanocobalamin

The American Diabetes Association (ADA) Standards of Care support considering GLP-1 receptor agonists, including dual agonists like tirzepatide, early in the treatment algorithm for type 2 diabetes, especially in patients with established cardiovascular disease, chronic kidney disease, or those requiring significant weight reduction

9 However, these recommendations fail to consider the reason for using the drug

When patients experience itching during GLP-1 therapy, the cause is often unrelated to the medication itself